AES CORP. DL-,01/ US00130H1059 /
08.11.2024 8:04:47 | Изменение -0.560 | Объем сделки | Бид21:59:49 | Предложение21:59:49 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
12.732EUR | -4.21% | 0 Оборот: 0.000 |
-Величина цены спроса: - | -Величина цены предложения: - | 9.02 млрдEUR | - | - |
Newsfile Corp
29.10
Perseverance Metals Announces New Critical Mineral Discoveries from the Lac Gayot Nickel-Copper-PGE ...
Newsfile Corp
19.09
Perseverance Metals Discovers New Nickel Zone, Yields 1.82% NiEq over 5.1 Meters at Lac Gayot Projec...
Newsfile Corp
17.09
Endurance Announces First 2024 Drill Results At The Reliance Gold Project, BC; Initial Six Holes Exp...
GlobeNewswire
30.08
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizu...
GlobeNewswire
28.08
Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
Newsfile Corp
26.08
ALX Resources Corp. Completes Prospecting and Sampling Programs at the Cannon Copper Project, Ontari...
GlobeNewswire
22.08
Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderat...
Newsfile Corp
20.08
Appia Confirms Outstanding Desorption Results From Its Ionic Adsorption Clay Targets Maia, Electra, ...
GlobeNewswire
15.08
Great Place To Work® Announces the 2024 Best Workplaces in Latin America Representing 3.8 Million Em...
GlobeNewswire
14.08
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic...
GlobeNewswire
14.08
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
12.08
Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib
GlobeNewswire
12.08
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at...
GlobeNewswire
08.08
Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница